ACCESSION: MSBNK-SMB_Measured-HSA001P0113026
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 23
COMMENT: RAW_SPEC {'17_posi_12136': {'bp': 108050.0, 'sum': 432879.0}, '19_posi_12388': {'bp': 77180.0, 'sum': 299905.0}, '19_posi_11440': {'bp': 96355.0, 'sum': 360209.0}, '18_posi_11906': {'bp': 88931.0, 'sum': 367211.0}, '19_posi_11906': {'bp': 100209.0, 'sum': 381928.0}, '19_posi_11822': {'bp': 95336.0, 'sum': 347213.0}, '18_posi_12114': {'bp': 92430.0, 'sum': 354550.0}, '19_posi_11587': {'bp': 85957.0, 'sum': 350734.0}, '12_posi_11401': {'bp': 93214.0, 'sum': 471461.0}, '19_posi_12220': {'bp': 104232.0, 'sum': 389465.0}, '7_posi_11422': {'bp': 87784.0, 'sum': 425897.0}, '18_posi_12032': {'bp': 87749.0, 'sum': 319136.0}, '17_posi_12320': {'bp': 90947.0, 'sum': 385070.0}, '18_posi_11654': {'bp': 89853.0, 'sum': 362629.0}, '19_posi_12053': {'bp': 88878.0, 'sum': 352921.0}, '19_posi_12136': {'bp': 90509.0, 'sum': 380481.0}, '8_posi_11400': {'bp': 83534.0, 'sum': 447480.0}, '6_posi_11423': {'bp': 83039.0, 'sum': 449479.0}, '14_posi_11402': {'bp': 72660.0, 'sum': 408938.0}, '18_posi_11567': {'bp': 95510.0, 'sum': 367288.0}, '19_posi_11672': {'bp': 87301.0, 'sum': 305892.0}, '18_posi_12238': {'bp': 86210.0, 'sum': 349148.0}, '18_posi_12367': {'bp': 85719.0, 'sum': 335750.0}}
COMMENT: RETENTION_TIME_STDEV 0.709
COMMENT: PRECURSOR_M/Z_RAW 113.070930
COMMENT: PRECURSOR_M/Z_STDEV 0.000033
COMMENT: PRECURSOR_IN_MS1 mz 113.070898; int 79.554; delta(ppm) 1.432132
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+CH3OH+H; mz 145.097136; int 73.963; cor 0.679
COMMENT: PROPOSED_ION_FORM M+NH4; M+CH3OH+H; mz 128.070601; int 13.654; cor 0.759
COMMENT: PROPOSED_ION_FORM M+CH3OH+H; M+NH4; mz 98.071268; int 14.869; cor 0.640
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+NH4; mz 89.070916; int 99.032; cor 0.776
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+CH3OH+H; mz 104.070586; int 345.538; cor 0.753
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.366; C5H8N2O; [M+H]+; delta(ppm) -0.365864
COMMENT: PROPOSED_MF SevenGoldenRules 0.410; C5H5NO; [M+NH4]+; delta(ppm) -0.410366
COMMENT: PROPOSED_MF SevenGoldenRules 0.487; C4H4N2; [M+CH3OH+H]+; delta(ppm) -0.487272
COMMENT: PROPOSED_MF SevenGoldenRules 0.549; C3H5NO; [M+ACN+H]+; delta(ppm) -0.549009
COMMENT: PROPOSED_MF MS-FINDER 3.064; C5H5NO; [M+NH4]+; delta(ppm) -0.365469
COMMENT: PROPOSED_MF MS-FINDER 3.034; C5H8N2O; [M+H]+; delta(ppm) -0.365469
COMMENT: PROPOSED_MF MS-FINDER 3.031; C3H5NO; [M+ACN+H]+; delta(ppm) 153226.132772
COMMENT: PROPOSED_MF MS-FINDER 2.628; C4H4N2; [M+CH3OH+H]+; delta(ppm) -0.365469
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.350; C5H8N2O; [M+H]+; delta(ppm) -0.365469
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.350; C4H4N2; [M+CH4O+H]+; delta(ppm) -0.365469
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.350; C3H5NO; [M+C2H3N+H]+; delta(ppm) -0.365469
COMMENT: PROPOSED_MF SIRIUS6_Sirius 10.350; C5H5NO; [M+H3N+H]+; delta(ppm) -0.365469
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.213; CH5FN2O; [M+CH4O+H]+; delta(ppm) -10.471000
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.213; C2H6FNO2; [M+H3N+H]+; delta(ppm) -10.471000
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.268; C3H6N5; [M+H]+; delta(ppm) 11.509192
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.268; CH3N4; [M+C2H3N+H]+; delta(ppm) 11.509192
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.268; C3H3N4; [M+H3N+H]+; delta(ppm) 11.509192
COMMENT: PROPOSED_MF SIRIUS6_Sirius -14.756; H7N3P; [M+CH4O+H]+; delta(ppm) -3.099170
COMMENT: PROPOSED_MF SIRIUS6_Sirius -14.756; CH8N2OP; [M+H3N+H]+; delta(ppm) -3.099170
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H8N2O; [M+H]+; delta(ppm) -0.365469
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H4N2; [M+CH4O+H]+; delta(ppm) -0.365469
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C3H5NO; [M+C2H3N+H]+; delta(ppm) -0.365469
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H5NO; [M+H3N+H]+; delta(ppm) -0.365469
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.686; AXJZCJSXNZZMDU-UHFFFAOYSA-N; [M+H]+; CC1=C(CO)NC=N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.452; HEEACTTWORLLPM-UHFFFAOYSA-N; [M+H]+; OCCC1=CNC=N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.250; NHMAWNBVHVQDPU-UHFFFAOYSA-N; [M+H]+; NC(=O)CCCC#N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.162; HEEACTTWORLLPM-UHFFFAOYSA-N; [M+H]+; UNPD196031
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.058; AXJZCJSXNZZMDU-UHFFFAOYSA-N; [M+H]+; 5-methyl-1H-imidazole-4-methanol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.047; NHMAWNBVHVQDPU-UHFFFAOYSA-N; [M+H]+; UNPD50229
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.921; HRPVXLWXLXDGHG-UHFFFAOYSA-N; [M+ACN+H]+; Acrylamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.904; ZSKGQVFRTSEPJT-UHFFFAOYSA-N; [M+NH4]+; 1H-Pyrrole-2-carboxaldehyde
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.835; PLAHHVUZRZZLQN-UHFFFAOYSA-N; [M+NH4]+; UNPD172647
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.627; UBQKCCHYAOITMY-UHFFFAOYSA-N; [M+NH4]+; 2-Hydroxypyridine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.604; WSGYTJNNHPZFKR-UHFFFAOYSA-N; [M+ACN+H]+; Ethylene cyanohydrin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.593; WUDNUHPRLBTKOJ-UHFFFAOYSA-N; [M+ACN+H]+; ethyl isocyanate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.541; WEQPBCSPRXFQQS-UHFFFAOYSA-N; [M+ACN+H]+; 4,5-dihydro-1,2-oxazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.524; WOFDVDFSGLBFAC-UHFFFAOYNA-N; [M+ACN+H]+; lactonitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.522; GCNTZFIIOFTKIY-UHFFFAOYSA-N; [M+NH4]+; 4-Hydroxypyridine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.522; GRFNBEZIAWKNCO-UHFFFAOYSA-N; [M+NH4]+; 3-pyridinol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.504; MNFORVFSTILPAW-UHFFFAOYSA-N; [M+ACN+H]+; azetidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.418; ILVXOBCQQYKLDS-UHFFFAOYSA-N; [M+NH4]+; pyridine N-oxide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.399; CZPWVGJYEJSRLH-UHFFFAOYSA-N; [M+CH3OH+H]+; Pyrimidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.366; SFJGCXYXEFWEBK-UHFFFAOYSA-N; [M+NH4]+; oxazepine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.333; ZQXSMRAEXCEDJD-UHFFFAOYSA-N; [M+ACN+H]+; N-vinylformamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.333; FJRPOHLDJUJARI-UHFFFAOYSA-N; [M+ACN+H]+; 2,3-dihydro-1,2-oxazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.333; IMSODMZESSGVBE-UHFFFAOYSA-N; [M+ACN+H]+; 4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.191; KYQCOXFCLRTKLS-UHFFFAOYSA-N; [M+CH3OH+H]+; Pyrazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.138; IAHFWCOBPZCAEA-UHFFFAOYSA-N; [M+CH3OH+H]+; Succinonitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.982; PBMFSQRYOILNGV-UHFFFAOYSA-N; [M+CH3OH+H]+; pyridazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.930; UQOCEEQQGFOLRM-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-methylideneimidazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.583; KMNIXISXZFPRDC-ONEGZZNKSA-N; [M+ACN+H]+; UNPD127487
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; HEEACTTWORLLPM-UHFFFAOYSA-N; [M+H]+; UNPD196031
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; PLAHHVUZRZZLQN-UHFFFAOYSA-N; [M+NH4]+; UNPD172647
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; WUDNUHPRLBTKOJ-UHFFFAOYSA-N; [M+ACN+H]+; ethyl isocyanate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; AXJZCJSXNZZMDU-UHFFFAOYSA-N; [M+H]+; 5-methyl-1H-imidazole-4-methanol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.954; ZSKGQVFRTSEPJT-UHFFFAOYSA-N; [M+NH4]+; 1H-Pyrrole-2-carboxaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.820; FJRPOHLDJUJARI-UHFFFAOYSA-N; [M+ACN+H]+; 2,3-dihydro-1,2-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.775; GCNTZFIIOFTKIY-UHFFFAOYSA-N; [M+NH4]+; 4-Hydroxypyridine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.773; MNFORVFSTILPAW-UHFFFAOYSA-N; [M+ACN+H]+; azetidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.769; IMSODMZESSGVBE-UHFFFAOYSA-N; [M+ACN+H]+; 4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.675; SFJGCXYXEFWEBK-UHFFFAOYSA-N; [M+NH4]+; oxazepine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.573; GRFNBEZIAWKNCO-UHFFFAOYSA-N; [M+NH4]+; 3-pyridinol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.573; UBQKCCHYAOITMY-UHFFFAOYSA-N; [M+NH4]+; 2-Hydroxypyridine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.480; ILVXOBCQQYKLDS-UHFFFAOYSA-N; [M+NH4]+; pyridine N-oxide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; NHMAWNBVHVQDPU-UHFFFAOYSA-N; [M+H]+; UNPD50229
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; CZPWVGJYEJSRLH-UHFFFAOYSA-N; [M+CH3OH+H]+; Pyrimidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; KYQCOXFCLRTKLS-UHFFFAOYSA-N; [M+CH3OH+H]+; Pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; PBMFSQRYOILNGV-UHFFFAOYSA-N; [M+CH3OH+H]+; pyridazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; IAHFWCOBPZCAEA-UHFFFAOYSA-N; [M+CH3OH+H]+; Succinonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; UQOCEEQQGFOLRM-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-methylideneimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; HRPVXLWXLXDGHG-UHFFFAOYSA-N; [M+ACN+H]+; Acrylamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; WSGYTJNNHPZFKR-UHFFFAOYSA-N; [M+ACN+H]+; Ethylene cyanohydrin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; WOFDVDFSGLBFAC-UHFFFAOYNA-N; [M+ACN+H]+; lactonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; ZQXSMRAEXCEDJD-UHFFFAOYSA-N; [M+ACN+H]+; N-vinylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; KMNIXISXZFPRDC-ONEGZZNKSA-N; [M+ACN+H]+; UNPD127487
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; WEQPBCSPRXFQQS-UHFFFAOYSA-N; [M+ACN+H]+; 4,5-dihydro-1,2-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.601; UBQKCCHYAOITMY-UHFFFAOYSA-N; [M+NH4]+; 1H-pyridin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.977; HRPVXLWXLXDGHG-UHFFFAOYSA-N; [M+ACN+H]+; prop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.505; CZPWVGJYEJSRLH-UHFFFAOYSA-N; [M+CH3OH+H]+; pyrimidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.397; GRFNBEZIAWKNCO-UHFFFAOYSA-N; [M+NH4]+; pyridin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.367; HEEACTTWORLLPM-UHFFFAOYSA-N; [M+H]+; 2-(1H-imidazol-5-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.302; KYQCOXFCLRTKLS-UHFFFAOYSA-N; [M+CH3OH+H]+; pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.204; AMSDWLOANMAILF-UHFFFAOYSA-N; [M+H]+; 2-imidazol-1-ylethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.105; ZSKGQVFRTSEPJT-UHFFFAOYSA-N; [M+NH4]+; 1H-pyrrole-2-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.073; AXJZCJSXNZZMDU-UHFFFAOYSA-N; [M+H]+; (5-methyl-1H-imidazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.057; GCNTZFIIOFTKIY-UHFFFAOYSA-N; [M+NH4]+; 1H-pyridin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.041; NDELSWXIAJLWOU-UHFFFAOYSA-N; [M+H]+; 2,5-dimethyl-4H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.016; WUDNUHPRLBTKOJ-UHFFFAOYSA-N; [M+ACN+H]+; isocyanatoethane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.958; MNFORVFSTILPAW-UHFFFAOYSA-N; [M+ACN+H]+; azetidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.949; ILVXOBCQQYKLDS-UHFFFAOYSA-N; [M+NH4]+; 1-oxidopyridin-1-ium
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.938; IMSODMZESSGVBE-UHFFFAOYSA-N; [M+ACN+H]+; 4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.917; VOTFXESXPPEARL-UHFFFAOYSA-N; [M+H]+; 3-methyl-4,5-dihydro-1H-pyridazin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.760; JXPVQFCUIAKFLT-UHFFFAOYSA-N; [M+H]+; 2,5-dimethyl-1H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.663; PYNDWPFZDQONDV-UHFFFAOYSA-N; [M+H]+; 3,4-dimethyl-1,2-oxazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.580; CFQPVBJOKYSPKG-UHFFFAOYSA-N; [M+H]+; 1,3-dimethylimidazol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.520; QZVRXWBKQJFSLP-UHFFFAOYSA-N; [M+H]+; 2-ethyl-1H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.500; ZGRVTNQAZFVQHA-UHFFFAOYSA-N; [M+H]+; 3-(3-methyldiazirin-3-yl)propanal
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.428; CDQDMLWGTVLQEE-UHFFFAOYSA-N; [M+H]+; (1-methylimidazol-2-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.322; ZITWSNQLWBKRBT-UHFFFAOYSA-N; [M+H]+; 2,3-dimethyl-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.318; DXFBKDSQMUFYLD-UHFFFAOYSA-N; [M+H]+; 2-pyrazol-1-ylethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.313; HAASCECTXNYFCI-UHFFFAOYSA-N; [M+H]+; morpholine-2-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.289; JRKFAGHOOSDGOQ-UHFFFAOYSA-N; [M+H]+; 4,5-dimethyl-1,3-dihydroimidazol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.273; XTSFUENKKGFYNX-UHFFFAOYSA-N; [M+H]+; bis(aziridin-1-yl)methanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.257; KIUHZRUPPGAVPY-UHFFFAOYSA-N; [M+H]+; 1-nitroso-3,6-dihydro-2H-pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.248; JEUPWQVILXWUFD-UHFFFAOYSA-N; [M+H]+; 2-(1H-imidazol-2-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.215; CHNYVNOFAWYUEG-UHFFFAOYSA-N; [M+NH4]+; 1H-pyrrole-3-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.212; BWDXTPHVKBEOKV-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrazol-5-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.208; HXUGVRAVZOPLQR-UHFFFAOYSA-N; [M+H]+; 4-ethyl-1,2-oxazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.201; ZVJZAKIRDRMLDW-UHFFFAOYSA-N; [M+NH4]+; 1-formylcyclopropane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.200; LDFWACKVZPQYOM-UHFFFAOYSA-N; [M+NH4]+; 2-formylcyclopropane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.197; HMNBBWXXNYVGPS-UHFFFAOYSA-N; [M+H]+; 3,5-dimethyl-1H-imidazol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.189; PRCIXKQBKWRGMA-UHFFFAOYSA-N; [M+H]+; 3,4-dimethyl-1,4-dihydropyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.179; YVQFZSHMTCZYMI-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.173; QUCPOTCGHLLGRZ-UHFFFAOYSA-N; [M+H]+; 4-ethyl-1,3-oxazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.169; QNXBWPAFCHPJMM-IMJSIDKUSA-N; [M+H]+; (1S,4S)-2,5-diazabicyclo[2.2.1]heptan-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.167; WCKJRVKJTUIAFW-UHFFFAOYSA-N; [M+H]+; (1-methylpyrazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; MQRMTENGXFRETM-UHFFFAOYSA-N; [M+H]+; (2-methyl-1H-imidazol-5-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.142; PXGQMYCEAWZJJF-UHFFFAOYSA-N; [M+H]+; (3-methylimidazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.125; WXHDUCRTLZRAEA-UHFFFAOYSA-N; [M+H]+; (3-methylpyrazol-1-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.118; FEMMUBXQRZJIIE-UHFFFAOYSA-N; [M+H]+; 2-ethyl-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.117; HTEIULCKLVWXAB-UHFFFAOYSA-N; [M+H]+; 2-aminopent-4-ynamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.110; JSJAXEJEZXYKLY-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(1,2-oxazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.108; POYXMTCMZAMQAW-UHFFFAOYSA-N; [M+H]+; 2,4-dimethyl-1H-pyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.107; UDFNSNRUEHXXNW-UHFFFAOYSA-N; [M+H]+; 1-(1,2-oxazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.104; CTXUDADWQSSNSC-UHFFFAOYSA-N; [M+H]+; 3,5-dimethyl-1H-pyrazol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.104; RQHDCARIPQMUKF-UHFFFAOYSA-N; [M+H]+; 2-(1,2-oxazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.104; GJHDTCHKZVZFHR-UHFFFAOYSA-N; [M+H]+; 2-(1,2-oxazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.103; HDVMZORZGNERAS-UHFFFAOYSA-N; [M+H]+; (4-methyl-1,2-oxazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.103; BCPOFENHPZDDTN-UHFFFAOYSA-N; [M+H]+; 3-ethyl-1,2-oxazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.102; JRPBQFVNYPRYAJ-UHFFFAOYSA-N; [M+H]+; (3-methyl-1,2-oxazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.100; SQFWQHCKCDSOJK-UHFFFAOYSA-N; [M+H]+; 1-(1H-imidazol-2-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.099; NLEAEGDBKRBJAP-UHFFFAOYSA-N; [M+H]+; (1-methylimidazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.098; HMIGLLCMSYLMJN-UHFFFAOYSA-N; [M+H]+; 2-amino-N-prop-2-ynylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.098; QSXREDPBMQKKAY-UHFFFAOYSA-N; [M+H]+; (1-methylpyrazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.089; WQFOGLYQVFBDEY-UHFFFAOYSA-N; [M+H]+; (2-methylpyrazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.089; QMWIAYLYKXMVPJ-UHFFFAOYSA-N; [M+H]+; 1-methyl-3-prop-2-ynylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.084; VCVSKQNPBCXRAM-UHFFFAOYSA-N; [M+H]+; N-methyl-1-(1,3-oxazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.084; GKVKHZDHOHYHRG-UHFFFAOYSA-N; [M+H]+; (4-methyl-1,3-oxazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.082; XPSASGPURGEDTD-UHFFFAOYSA-N; [M+H]+; (4-methyl-1,3-oxazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.081; ZFKWYIYSYDLCCG-UHFFFAOYSA-N; [M+H]+; (2-methyl-1,3-oxazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.079; MFAOMQZXGBUBMZ-UHFFFAOYSA-N; [M+H]+; 1-(1,3-oxazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.077; CWJDVDQXFIORGV-UHFFFAOYSA-N; [M+H]+; 1-(1,3-oxazol-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.077; RWIPJFQIYWOQKH-UHFFFAOYSA-N; [M+H]+; 2-(1,3-oxazol-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.077; IAHFWCOBPZCAEA-UHFFFAOYSA-N; [M+CH3OH+H]+; butanedinitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.076; GOADWLCEMFNDHJ-UHFFFAOYSA-N; [M+H]+; 1-(1,3-oxazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.076; HHGLDCRFUVVQBP-UHFFFAOYSA-N; [M+H]+; (5-methyl-1,3-oxazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.075; XPRVSYXHPUYSGF-UHFFFAOYSA-N; [M+ACN+H]+; azetidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.053; CABHXTNYNGUYFF-UHFFFAOYSA-N; [M+H]+; 1-(1H-pyrazol-5-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.048; YTLIISRHCPJHLB-UHFFFAOYSA-N; [M+H]+; 2-isocyano-N,N-dimethylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.042; BLINWUJXZICUTH-UHFFFAOYSA-N; [M+H]+; (5-methyl-1H-imidazol-2-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.040; SYDSMFCVIJNHEN-UHFFFAOYSA-N; [M+H]+; (5-methyl-1H-pyrazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.038; IQHUZSDQPYHSAS-UHFFFAOYSA-N; [M+H]+; 1-(1H-imidazol-5-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.026; HVLNVBVNWISWQC-UHFFFAOYSA-N; [M+H]+; (5-methyl-1H-pyrazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.025; QIQGLPRCMHFDEO-UHFFFAOYSA-N; [M+H]+; (4-methyl-1H-pyrazol-5-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.015; MSAGLWTVMUDVDT-UHFFFAOYSA-N; [M+NH4]+; 3-oxocyclobutane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.013; PTXNIPMCMAOFKZ-UHFFFAOYSA-N; [M+NH4]+; 2-oxocyclobutane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.867; KPCCPWBBOMBLEC-IUYQGCFVSA-N; [M+NH4]+; (1R,4S)-2-azabicyclo[2.2.0]hex-5-en-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.864; PBMFSQRYOILNGV-UHFFFAOYSA-N; [M+CH3OH+H]+; pyridazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.793; WSGYTJNNHPZFKR-UHFFFAOYSA-N; [M+ACN+H]+; 3-hydroxypropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.779; ZQXSMRAEXCEDJD-UHFFFAOYSA-N; [M+ACN+H]+; N-ethenylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.776; CDHFJMAKBNRMFE-UHFFFAOYSA-N; [M+NH4]+; 5-ethenyl-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.771; BOQOXLAQTDFJKU-UHFFFAOYSA-N; [M+H]+; morpholine-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.713; VHZVSAXCIKCRAK-UHFFFAOYSA-N; [M+H]+; 4,5-dimethyl-1,3-oxazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.712; MATJPVGBSAQWAC-UHFFFAOYSA-N; [M+H]+; 2-cyano-N,N-dimethylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.705; QITPLPZRGCEKHE-UHFFFAOYSA-N; [M+H]+; N-(cyanomethyl)-N-methylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.663; AZVWIMLQRLKLHH-UHFFFAOYSA-N; [M+H]+; (5-methyl-1,2-oxazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.658; WOFDVDFSGLBFAC-UHFFFAOYSA-N; [M+ACN+H]+; 2-hydroxypropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.652; INSUSOZBMWJGDG-UHFFFAOYSA-N; [M+H]+; 3,5-dimethyl-1,2-oxazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.607; IQCHZCYHDCDSFI-UHFFFAOYSA-N; [M+H]+; 2-cyano-2-methylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.602; JKVMPILAJBLISV-UHFFFAOYSA-N; [M+H]+; (3-methyl-1,2-oxazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.555; XJGYZYRJUUMCAP-UHFFFAOYSA-N; [M+H]+; 1-(methoxymethyl)imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.554; RIFXNGHPOLZJLA-UHFFFAOYSA-N; [M+H]+; N,5-dimethyl-1,2-oxazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.547; PLVWUINOWYHRAA-UHFFFAOYSA-N; [M+H]+; ethyl N-cyanoethanimidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.547; VPANVNSDJSUFEF-UHFFFAOYSA-N; [M+H]+; 4,5-dimethyl-1,2-oxazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.544; WBQTVZALNOJHNB-UHFFFAOYSA-N; [M+H]+; 2-(methoxymethyl)-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.542; CJTDBBPQNDKTLR-UHFFFAOYSA-N; [M+H]+; ethyl 2-cyanoethanimidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.542; INRPZCXQEPGTQB-UHFFFAOYSA-N; [M+H]+; 5-ethyl-1,2-oxazol-3-amine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C5H9N2O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 23.787
MS$FOCUSED_ION: PRECURSOR_M/Z 113.070898
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-9800000000-5399f0d28c05a91232c9
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.0495851 173.9324 56.050217 0.7850 21.50 0.2547 22 f{C3H6N1}/1.95ppm,p-C2H3N1O1
  67.0542082 125.4630 67.054844 1.4317 27.62 0.1374 23 f{C5H7}/-0.27ppm,p-H2N2O1
  68.0494147 79.4518 68.050046 0.8817 17.96 -0.0464 23 f{C4H6N1}/-0.89ppm,p-C1H3N1O1
  70.0651553 270.8776 70.065775 1.2417 193.86 -0.1117 23 f{C4H8N1}/0.42ppm,p-C1H1N1O1
  71.0490953 48.9019 71.049709 1.2245 14.82 0.1779 22 f{C4H7O1}/-0.65ppm,p-C1H2N2
  71.0602997 48.7897 71.060913 1.3510 13.30 -0.0481 21 f{C3H7N2}/-1.05ppm,p-C2H2O1
  84.0682326 141.3471 84.068724 1.4155 22.82 0.2856 23 f{C4H8N2}/0.39ppm,p-C1H1O1
  84.0807932 41.4239 84.081285 1.7126 9.86 -0.0088 19 ?
  85.0648653 51.6263 85.065345 1.2579 12.44 0.4421 19 f{C5H9O1}/0.87ppm,p-N2
  85.0760378 729.0746 85.076517 0.3761 58.41 0.5830 23 f{C4H9N2}/0.15ppm,p-C1O1
  95.0491504 124.9828 95.049510 1.2520 27.17 0.3202 23 ?
  96.0808493 242.0851 96.081202 0.9992 189.42 -0.0128 23 ?
  113.0346377 119.0382 113.034832 1.1766 20.12 0.4180 23 ?
  113.0597632 136.9186 113.059957 1.6009 19.35 0.4822 23 ?
  113.0709825 999.0000 113.071176 0.3891 11.28 1.0000 23 f{C5H9N2O1}/0.38ppm,p
  113.0901654 49.8771 113.090359 2.1929 12.61 0.2279 17 ?
  113.1073338 613.5356 113.107527 0.3890 163.18 -0.1186 23 ?
PK$NUM_PEAK: 17
PK$PEAK: m/z int. rel.int.
  56.049585 173.93 173
  67.054208 125.46 125
  68.049415 79.45 79
  70.065155 270.88 270
  71.049095 48.90 48
  71.060300 48.79 48
  84.068233 141.35 141
  84.080793 41.42 41
  85.064865 51.63 51
  85.076038 729.07 729
  95.049150 124.98 124
  96.080849 242.09 242
  113.034638 119.04 119
  113.059763 136.92 136
  113.070982 999.00 999
  113.090165 49.88 49
  113.107334 613.54 613
//
